Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Pittsburgh
Sponsor:
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00524290
First received: August 31, 2007
Last updated: December 16, 2015
Last verified: December 2015
  Purpose
The objectives of this multinational study are to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population. We also aim to characterize the molecular epidemiology of this remarkable organism in an attempt to further understand its transmission dynamics on a global level and to determine whether increased pathogenicity is geographically dependent.

Condition
Acinetobacter Infections

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol

Further study details as provided by University of Pittsburgh:

Estimated Enrollment: 100
Study Start Date: April 2009
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Detailed Description:
Medical records will be reviewed and information collected to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
acinetobacter infections
Criteria

Inclusion Criteria:

  • Patients with Acinetobacter infections

Exclusion Criteria:

  • Those that do not meet entry criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00524290

Contacts
Contact: David Paterson, MD 412-648-6553 david.antibiotics@gmail.com
Contact: Diana Lynn Pakstis, RN, BSN 412-648-6553 pakstisdl@dom.pitt.edu

Locations
United States, Pennsylvania
University of Pittsburgh Medical Center Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: David Paterson, MD    412-648-6553    david.antibiotics@gmail.com   
Contact: Diana Lynn Pakstis, RN, BSN    412-648-6553    pakstisdl@dom.pitt.edu   
Principal Investigator: David Paterson, MD         
Sub-Investigator: Anton Peleg, MD         
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: David Paterson, MD University of Pittsburgh
  More Information

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00524290     History of Changes
Other Study ID Numbers: PRO07080043 
Study First Received: August 31, 2007
Last Updated: December 16, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
Acinetobacter
infection
isolate

Additional relevant MeSH terms:
Infection
Communicable Diseases
Acinetobacter Infections
Moraxellaceae Infections
Gram-Negative Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on August 25, 2016